Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study on the Use of Sarilumab in Patients With COVID-19 Infection

NCT04386239 is registered in ClinicalTrials.gov with ASST Fatebenefratelli Sacco as lead sponsor.

NCT NCT04386239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04386239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study on the Use of Sarilumab in Patients With COVID-19 Infection
Lead sponsor
ASST Fatebenefratelli Sacco
Phase
Phase 1
Overall status
Withdrawn
Start date
January 1, 2021
Completion date
January 1, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19